A potential silver lining of delaying the second dose
Nat Immunol
.
2022 Mar;23(3):349-351.
doi: 10.1038/s41590-022-01143-z.
Authors
David R Martinez
1
,
Eng Eong Ooi
2
Affiliations
1
Department of Epidemiology, The University of North Carolina at Chapel Hill, Chapel Hill, NC, USA. david.rafael.martinez@gmail.com.
2
Programme in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore, Singapore. engeong.ooi@duke-nus.edu.sg.
PMID:
35190721
DOI:
10.1038/s41590-022-01143-z
No abstract available
Publication types
Comment
MeSH terms
BNT162 Vaccine*
COVID-19 Vaccines
COVID-19*
Humans
Immunity, Humoral
RNA, Messenger
T-Lymphocytes
Vaccination
Substances
COVID-19 Vaccines
RNA, Messenger
BNT162 Vaccine